Outcome of heart rate variability and ventricular late potentials after liver transplantation for familial amyloidotic polyneuropathy

References

• Saraiva M, Costa P, Birken S, Goodman S. Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Phys 1983; 96: 261–270
   PubMedGoogle Scholar
• Benson M. Amyloidosis. The metabolic and molecular basis of inherited disease, C R Scriver, A L Beaudet, W S Sly, D Valle. McGraw-Hill, New York 1995; 4159
   Google Scholar
• Suhr O B, Herlenius G, Friman S, Ericzon B G. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000; 6: 263–276
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon B G, Groth C G, Steen L, Suhr O, Andersen O, Wallin B G, Seymour A, Richardson S, Hawkins P N. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341: 1113–1116
   PubMed Web of Science ®Google Scholar
• Ando Y, Suhr O B. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid. Int J Exp Clin Invest 1998; 5: 288–300
   Google Scholar
• Olofsson B O, Suhr O, Niklasson U, Wiklund U, Bjerle P, Beckman A. Assessment of autonomic nerve function in familial amyloidotic polyneuropathy – a clinical study based of spectral analysis of heart rate variability. Amyloid. Int J Exp Clin Invest 994; 1: 240–246
   Google Scholar
• Kinoshita O, Hongo M, Saikawa Y, Katsuyama T, Tanaka M, Takeda M, Yamamoto H, Isobe M, Sekiguchi M. Heart rate variability in patients with familial amyloid polyneuropathy. Pacing Clin Electrophysiol 1997; 20: 2949–2953
   PubMed Web of Science ®Google Scholar
• Morelli S, Carmenini E, Sgreccia A, Francia A. Heart rate variability and familial amyloidosis. Int J Cardiol 2002; 83: 295–297
   Google Scholar
• Suhr O B. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications. Amyloid. J Protein Folding Disord 2003; 10(Suppl. 1)77–83
   PubMed Web of Science ®Google Scholar
• Ando Y, Tanaka Y, Ando E, Yamashita T, Nishida Y, Tashima K, Suga M, Uchino M, Ando M. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 1995; 345: 195–196
   PubMed Web of Science ®Google Scholar
• Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, Adams D, Samuel D, Merlet P, Syrota A. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 2006; 85: 229–238
   PubMed Web of Science ®Google Scholar
• Beckman A, Bjerle P, Olofsson B. Electrocardiographic findings in familial amyloidotic polyneuropathy. Am J Noninvas Cardiol 1992; 6: 192–196
   Google Scholar
• Falcao De Freitas A, Barbedo A. Conduction disturbances in 190 patients with familial amyloidotic polyneuropathy (Andrade's type). Adv Cardiol 1978; 21: 206–209
   PubMedGoogle Scholar
• Eriksson P, Karp K, Bjerle P, Olofsson B O. Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy. Br Heart J 1984; 51
   Google Scholar
• Hörnsten R, Wiklund U, Olofsson B O, Jensen S M, Suhr O B. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004; 78: 112–116
   PubMed Web of Science ®Google Scholar
• Wiklund U, Hörnsten R, Karlsson M, Suhr O, Jensen S M. Abnormal heart rate variability and subtle atrial arrhythmia in patients with familial amyloidotic polyneuropathy. Ann Noninvasive Electrocardiol 2008, in press
   Google Scholar
• Woo M A, Stevenson W G, Moser D K, Trelease R B, Harper R M. Patterns of beat-to-beat heart rate variability in advanced heart failure. Am Heart J 1992; 123: 704–710
   PubMed Web of Science ®Google Scholar
• Stein P K, Domitrovich P P, Hui N, Rautaharju P, Gottdiener J. Sometimes higher heart rate variability is not better heart rate variability: results of graphical and nonlinear analyses. J Cardiovasc Electrophysiol 2005; 16: 954–959
   PubMed Web of Science ®Google Scholar
• Rydberg A, Karlsson M, Hörnsten R, Wiklund U. Can analysis of heart rate variability predict arrhythmia in children with Fontan circulation?. Pediatr Cardiol 2008; 29: 50–55
   Google Scholar
• Cain M E, Anderson J, Arnsdorf M F, Mason J W, Scheinman M M, Waldo A L. Signal-averaged electrocardiography. JACC 1996; 27: 238–249
   Google Scholar
• Kanovsky M S, Falcone R A, Dresden C A, Josephson M E, Simson M B. Identification of patients with ventricular tachycardia after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring, and cardiac catheterization. Circulation 1984; 70: 264–270
   PubMed Web of Science ®Google Scholar
• Hörnsten R, Wiklund U, Suhr O B, Jensen S M. Ventricular late potentials in familial amyloidotic polyneuropathy. J Electrocardiol 2006; 39: 57–62
   PubMed Web of Science ®Google Scholar
• Engel G, Beckerman J G, Froelicher V F, Yamazaki T, Chen H A, Richardson K, McAuley R J, Ashley E A, Chun S, Wang P J. Electrocardiographic arrhythmia risk testing. Curr Probl Cardiol 2004; 29: 365–432
   PubMed Web of Science ®Google Scholar
• Oppenheim A, Schafer R W. Digital signal processing. Prentice-Hall, Engewoods Cliffs, NJ 1975
   Google Scholar
• Tulppo M P, Makikallio T H, Takala T E, Seppanen T, Huikuri H V. Quantitative beat-to-beat analysis of heart rate dynamics during exercise. Am J Physiol 1996; 271: H244–252
   PubMed Web of Science ®Google Scholar
• Breithardt G, Cain M E, el-Sherif N, Flowers N, Hombach V, Janse M, Simson M B, Steinbeck G. Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology. Eur Heart J 1991; 12: 473–480
   Google Scholar
• Olofsson B O, Backman C, Karp K, Suhr O. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy. Transplantation 2002; 73: 745–751
   PubMed Web of Science ®Google Scholar
• Atkison P, Joubert G, Barron A, Grant D, Paradis K, Seidman E, Wall W, Rosenberg H, Howard J, Williams S. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet 1995; 345: 894–896
   PubMed Web of Science ®Google Scholar
• Roberts C A, Stern D L, Radio S J. Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant. Transplantation 2002; 74: 817–821
   PubMed Web of Science ®Google Scholar
• Lang K, Wikstrom L, Danielsson A, Tashima K, Suhr O B. Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand J Gastroenterol 2000; 35: 985–989
   PubMed Web of Science ®Google Scholar
• Suhr O B, Anan I, Ahlstrom K R, Rydh A. Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portuguese type (Val30Met). Amyloid 2003; 10: 121–126
   PubMed Web of Science ®Google Scholar
• Yazaki M, Mitsuhashi S, Tokuda T, Kametani F, Takei Y I, Koyama J, Kawamorita A, Kanno H, Ikeda S I. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007; 7: 235–242
   PubMed Web of Science ®Google Scholar
• Eriksson A, Eriksson P, Olofsson B O, Thornell L E. The sinoatrial node in familial amyloidosis with polyneuropathy. A clinico-pathological study of nine cases from northern Sweden. Virchows Arch A Pathol Anat Histopathol 1984; 402: 239–246
   PubMedGoogle Scholar
• Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005; 62: 1057–1062
   PubMed Web of Science ®Google Scholar
• Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993; 43: 288–294
   PubMed Web of Science ®Google Scholar
• Dubrey S W, Bilazarian S, LaValley M, Reisinger J, Skinner M, Falk R H. Signal-averaged electrocardiography in patients with AL (primary) amyloidosis. Am Heart J 1997; 134: 994–1001
   PubMed Web of Science ®Google Scholar
• Grimm W, Liedtke J, Muller H H. Prevalence of potential noninvasive arrhythmia risk predictors in healthy, middle-aged persons. Ann Noninvasive Electrocardiol 2003; 8: 37–46
   Google Scholar
• Marques-Vidal P, Ruidavets J B, Prouteau N, Casteignau G, Delay M, Ferrieres J. Prevalence of late potentials in a sample of 487 healthy, middle-aged men from southwestern France. Pacing Clin Electrophysiol 2000; 23: 888–890
   Google Scholar